NCT04767152View on ClinicalTrials.gov

Evaluation of Brain Changes in ALL Patients on Therapy

NARecruitingINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

February 16, 2021

Primary Completion Date

January 1, 2026

Study Completion Date

January 21, 2026

Conditions
Acute Leukemia
Interventions
DIAGNOSTIC_TEST

MRI

The quantitative assessment of MRI parameters, The macromolecular proton fraction (MPF) (%) in brain tissue. Before the start of therapy - the starting point. Point 2. 36 ± 3 days after the start of the therapy. Point 3. After completing three courses of consolidation chemotherapy. Point 4. After confirmation of remission status, optionally provided.

Trial Locations (1)

117997

RECRUITING

Dmitry Rogachev Federal Research and Clinical Centre of Paediatric Haematology, Oncology and Immunology, Moscow

All Listed Sponsors
lead

Federal Research Institute of Pediatric Hematology, Oncology and Immunology

OTHER